2013-01-10 11:08:02 - “Direct-To-Consumer genetic tests have been growing steadily and are now expected to be one of the leading traditions in the global genetic testing market,” says RNCOS.
According to a new report by RNCOS, “Global Genetic Testing Market Forecast to 2015”, direct-to-consumer genetic tests have emerged amid a period of rapid growth especially due to the minimum regulations posed on them. Amongst several markets, developed countries have been effectively witnessing a surge in the number of companies offering testing services over the internet. Countries including US, UK, and Canada have the leading edge in this category as compared to others. DTC tests are commonly done for mutations that cause cystic fibrosis, hemochromatosis, and Fragile X syndrome.
The global genetic testing market has seen rapid evolution and greater acceptance has been observed in the market on account of the specificity that these tests offer, thereby driving the market to
more favorable outcomes. Companion diagnostics in particular are poised for growth mainly boosted by the discovery of new biomarkers for oncology treatment. Geographically, US dominates the genetic testing market driven by the immense desire of the healthcare community to use new technologies and interpret their effectiveness. Overall, the global genetic testing market may grow at a healthy CAGR of around 26% during 2012-2015.
The report entitled, “Global Genetic Testing Market Forecast to 2015”, provides an in-depth analysis of the current and future status of global genetic testing market and evaluates the role of genetic testing in diseases, such as Cancer, Cystic Fibrosis, and Alzheimer. The 95 pages report also gives a comprehensive overview of the Direct-to-Consumer (DTC) gene-based tests that have gained significant attraction due to their marketing and distribution pattern. The study is an outcome of an extensive research and in-depth analysis of the current Global Genetic Testing Market that effectively measured the consumer behavior patterns within the US and Canada. Moreover, it provides an optimum insight into the emerging sectors namely Next-Generation Sequencing and Genomic Biomarkers to analyze new growth avenues. An in-depth assessment of prominent companies offering tools/equipments in the genetic testing market has also been covered.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM445.htm
Some of our Related Reports are as follows:
- US Proton Therapy Market Analysis to 2017 (http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)
- US Cardiac Device Market Analysis (http://www.rncos.com/Report/IM441.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.